• Dehydroabietic Acid: Dual PPAR-α/γ Agonist for Metabolic Res

  2026-05-08

  Dehydroabietic acid, a robust dual PPAR-α/γ agonist, enables high-fidelity investigations of lipid metabolism regulation and insulin sensitivity improvement. Its unique physicochemical profile and rigorous APExBIO quality controls empower reproducible metabolic disorder research and targeted assay optimization.

• Magnetic Bispecific Nano-antibody Drives In Vivo CAR-T Mimic

  2026-05-07

  This study introduces a magnetic bispecific nano-antibody (M-BiNanoAb) platform that enables in vivo generation and magnetic navigation of CAR-T-mimicking cells for solid tumor therapy. The approach shows promise for overcoming major barriers in solid tumor immunotherapy by facilitating T cell infiltration and cytotoxic activity within the tumor microenvironment.

• Live-Dead Bacterial Staining Kit: Optimizing Bacterial Viabi

  2026-05-07

  Unlock precise, dual-fluorescent assessment of bacterial viability with the Live-Dead Bacterial Staining Kit. This article bridges protocol mastery, troubleshooting, and advanced applications—empowering microbiology researchers to tackle complex infection models and nanomaterial efficacy studies with confidence.

• CD147+ sEVs Drive HCC Angiogenesis via PI3K/Akt Pathway Acti

  2026-05-06

  Huang et al. identify CD147-positive small extracellular vesicles (sEVs) from hepatocellular carcinoma (HCC) cells as both a promising diagnostic marker and a functional promoter of angiogenesis, acting through the PI3K/Akt pathway. Their study details the mechanistic, quantitative, and diagnostic relevance of sEV-associated CD147 in HCC progression, underscoring new avenues for targeted research on tumor vascularization.

• Reserpine (SKU N1867): Technical Guidance for Research Workf

  2026-05-06

  Reserpine (SKU N1867) addresses the need for a high-purity, reproducible agent in neurotransmitter depletion and antihypertensive mechanism research. It is designed strictly for laboratory and preclinical workflows, not for diagnostic or medical use. Proper handling and protocol adherence are essential for reliable results.

• Thiazovivin (A5506): Technical Guidance for ROCK Inhibition

  2026-05-05

  Thiazovivin is a high-purity ROCK inhibitor used to enhance fibroblast reprogramming efficiency and improve human embryonic stem cell survival in stem cell research workflows. It should be applied within validated protocols for induced pluripotent stem cell generation and is not intended for clinical or diagnostic use. Researchers should follow recommended storage, preparation, and application parameters to maintain compound activity and maximize experimental reproducibility.

• Tunicamycin: Optimizing ER Stress & Inflammation Workflows

  2026-05-05

  Tunicamycin stands as a gold-standard N-glycosylation inhibitor for dissecting endoplasmic reticulum stress and inflammation in cell and animal models. This guide delivers workflow enhancements, troubleshooting, and practical insights for researchers leveraging APExBIO’s Tunicamycin in advanced biomedical investigations.

• S63845 MCL1 Inhibitor: Precision Apoptosis Activation in Can

  2026-05-04

  S63845, a highly selective MCL1 inhibitor, is transforming apoptosis research through potent, targeted activation of the mitochondrial pathway in hematological and solid tumor models. This article delivers practical protocols, advanced combinatorial strategies, and troubleshooting insights to empower scientists seeking robust, reproducible results.

• Direct Mouse Genotyping Kit: Fast, Reliable PCR from Mouse T

  2026-05-04

  The Direct Mouse Genotyping Kit streamlines mouse DNA workflows by enabling rapid PCR directly from tissue samples—eliminating the need for purification and maximizing throughput. With optimized lysis buffers and a ready-to-use PCR master mix with dye, researchers gain robust, reproducible genotyping ideal for high-throughput screening in biomedical research settings.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-05-03

  The referenced study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal subpopulations, capturing the complexity of the tumor microenvironment. This approach reveals how stromal components modulate biomarker expression and drug responses, advancing the field of preclinical cancer research and personalized therapy.

• Salinomycin: Molecular Mechanisms and Assay Optimization in

  2026-05-02

  Explore Salinomycin, a polyether ionophore antibiotic, through a molecular lens—uncovering its novel anti-cancer actions, experimental parameters, and toxicity insights. This article uniquely bridges mechanistic science with practical assay design for hepatocellular carcinoma research.

• WAY-100635: Strategic Insights for Translational 5-HT1A Anta

  2026-05-02

  This article delivers a thought-leadership perspective for translational neuroscience teams investigating serotonin 5-HT1A receptor mechanisms. By integrating the mechanistic rigor of WAY-100635 with emerging evidence from affective pain research, we offer actionable guidance on protocol optimization, cross-domain insights, and workflow pitfalls. Drawing on both product intelligence and recent pioneering studies, this piece stands apart by bridging advanced pharmacological utility with real translational impact.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Insig

  2026-05-01

  This study identifies moesin as a novel biomarker correlating with endothelial injury in sepsis, demonstrating mechanistic links to the Rock1/MLC and NF-κB pathways. These findings advance the understanding of sepsis progression and inform the design of pH and ion transport assays in vascular research.

• Acetoacetic Acid Sodium Salt: Applied Workflows in Energy Me

  2026-04-30

  Acetoacetic acid sodium salt empowers high-precision quantification of ketone body metabolites, supporting advanced research into energy metabolism and diabetic metabolic imbalance. This article delivers actionable protocol enhancements, comparative workflow insights, and troubleshooting strategies to maximize reproducibility and data quality in translational and bench research.

• Thioredoxin System’s Role in CHK1 Inhibitor Sensitivity in N

  2026-04-30

  This study demonstrates that the thioredoxin (Trx) antioxidant system governs non-small cell lung cancer (NSCLC) cell sensitivity to CHK1 inhibitors through redox-mediated control of ribonucleotide reductase (RNR). By elucidating a mechanistic link between redox regulation and DNA precursor availability, the research points toward rational combination therapies to overcome resistance and minimize toxicity in cancer treatment.

453 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page